{
    "fund_name": "WisdomTree Emerging Markets 3x Daily Leveraged",
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "3x daily leverage",
        "Synthetic replication via swaps",
        "Complex index (Emerging Equities Rolling Futures Index)",
        "Futures rolling strategy",
        "Counterparty risk exposure",
        "High risk profile (7/7)",
        "Non-UCITS structure",
        "Daily compounding effect"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex under MiFID II due to multiple factors: 1) 3x daily leverage creates significant volatility and compounding effects that are difficult for retail investors to understand; 2) Synthetic replication via swaps introduces counterparty risk and requires understanding of derivative mechanics; 3) The underlying index (Emerging Equities Rolling Futures Index) involves futures contracts with rolling strategies that create tracking error risks; 4) The product is not UCITS compliant and carries a 7/7 risk rating; 5) The daily reset of leverage creates non-linear performance characteristics; 6) The product is explicitly stated to be 'not simple and may be difficult to understand' in the KIID. The PRIIPs KID also contains a comprehension warning, reinforcing the complexity assessment. While the product is fully collateralized, the combination of leverage, derivatives, and complex index construction makes it unsuitable for retail investors without specialized knowledge.",
    "confidence": 95,
    "counter_arguments": "One might argue that the product is fully collateralized and trades on exchange like a standard ETF, suggesting it could be considered non-complex. However, the MiFID II guidelines specifically identify leveraged products with daily compounding effects as complex due to their non-intuitive performance characteristics and higher risk profiles. The explicit warnings in the documentation about the product being difficult to understand further support the complex classification.",
    "risk_profile_alignment": "The 7/7 risk rating in the KIID aligns perfectly with the complex classification, as the product's leveraged nature and derivative exposure create significant potential for rapid capital loss. The risk disclosures explicitly warn about the potential for total loss of investment in adverse market conditions, which is characteristic of complex products."
}